Sg Americas Securities, LLC Spectrum Pharmaceuticals Inc Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$0.63 - $1.59 $199,010 - $502,265	-315,890 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$1.27 - $2.42 $189,402 - $360,909	149,136 Added 89.43%	315,890 $401,000
Q3 2021 Nov 01, 2021	BUY	$2.15 - $3.82 $334,340 - $594,036	155,507 Added 1382.65%	166,754 $364,000
Q2 2021 Aug 12, 2021	SELL	$2.89 - $4.45 $76,148 - $117,253	-26,349 Reduced 70.08%	11,247 $42,000
Q1 2021 May 13, 2021	SELL	$2.9 - $4.09 $152,487 - $215,060	-52,582 Reduced 58.31%	37,596 $123,000
Q4 2020 Feb 04, 2021	BUY	$3.38 - $5.14 $253,503 - $385,505	75,001 Added 494.18%	90,178 $308,000
Q3 2020 Nov 09, 2020	SELL	$2.99 - $4.9 $27,490 - $45,050	-9,194 Reduced 37.73%	15,177 $62,000
Q2 2020 Jul 20, 2020	SELL	$2.11 - $3.38 $11,334 - $18,157	-5,372 Reduced 18.06%	24,371 $82,000
Q1 2020 Apr 30, 2020	BUY	$1.83 - $3.45 $54,429 - $102,613	29,743 New	29,743 $69,000
Q3 2019 Nov 04, 2019	SELL	$7.03 - $9.7 $136,642 - $188,538	-19,437 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$7.36 - $11.26 $949,741 - $1.45 Million	-129,041 Reduced 86.91%	19,437 $167,000
Q1 2019 Apr 29, 2019	BUY	$9.08 - $11.84 $1.35 Million - $1.76 Million	148,478 New	148,478 $1.59 Million
Q3 2018 Nov 06, 2018	SELL	$16.52 - $24.82 $118,167 - $177,537	-7,153 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$14.31 - $21.75 $10,689 - $16,247	747 Added 11.66%	7,153 $150,000
Q1 2018 May 03, 2018	BUY	$16.09 - $23.07 $103,072 - $147,786	6,406 New	6,406 $103,000
Q4 2017 Jan 24, 2018	SELL	$13.36 - $20.73 $612,836 - $950,905	-45,871 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$8.75 - $14.07 $401,371 - $645,404	45,871	45,871 $645,000

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account